French biotech raises $75M for new cell therapy manufacturing tech, Parkinson’s treatment

A French cell therapy startup is getting two new offices in opposite parts of the world, and a new CEO to boot as it announces a new round of funding Monday.

Biotech TreeFrog Therapeutics, which is focused on stem cell therapy, closed a $75 million Series...

Click to view original post